Position in AMLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,596,790
+$671,922 QoQ
Shares Held
114,877
+50.0% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
15 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Derivatives in AMLX
reported options exposure · as of Dec 31, 2024CallValue
$0
CallShares
0
PutValue
$63,504
PutShares
16,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Squarepoint Ops LLC holds $163,878,430 across 40 Drug Manufacturers - Specialty & Generic names. AMLX ranks #15 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
487,953 | $64,282,928 | |
| 2 | VTRS |
Viatris Inc
|
2,273,599 | $30,716,322 | |
| 3 | ALKS |
Alkermes plc.
|
277,619 | $9,816,607 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
158,093 | $7,612,177 | |
| 5 | LQDA |
Liquidia Corp
|
161,689 | $6,102,142 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
167,580 | $5,047,509 | |
| 7 | PRGO |
PERRIGO Co plc
|
464,742 | $4,991,329 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
63,538 | $4,886,072 |
All Filings in AMLX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,596,790 | 114,877 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $924,868 | 76,562 | Shares | Defined | 2026-02-13 | |
| 2025-06-30 | $260,521 | 40,643 | Shares | Defined | 2025-08-27 | |
| 2025-03-31 | $268,505 | 75,849 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $63,504 | 16,800 | Put | Defined | 2025-02-14 | |
| 2024-12-31 | $284,573 | 75,284 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $155,536 | 48,005 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $517,894 | 272,576 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $452,437 | 159,309 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $492,384 | 33,450 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $732,400 | 40,000 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $988,121 | 45,810 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,691,240 | 91,726 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,478,000 | 40,000 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,176,444 | 41,792 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $192,750 | 15,000 | Shares | Defined | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||